Live Updates > Live Update Details
2025-10-30 03:51:13
GlaxoSmithKline (GSK) shares rose 4.9% in late trading on Wednesday after the company announced a return to profitability in the third quarter and year-over-year revenue growth. In the three months ending September 30, profit attributable to shareholders reached £2.01 billion, compared to a loss of £58 million in the same period last year, with earnings per share rising to £0.491 from a loss of £0.014. GSK raised its full-year 2025 revenue growth guidance to 6% to 7%, core operating profit to 9% to 11%, and earnings per share to 10% to 12%.
